Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.

Saha A, Ellison D, Thomas GJ, Vallath S, Mather SJ, Hart IR, Marshall JF.

J Pathol. 2010 Sep;222(1):52-63. doi: 10.1002/path.2745.

PMID:
20629113
3.

Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model.

Hausner SH, Abbey CK, Bold RJ, Gagnon MK, Marik J, Marshall JF, Stanecki CE, Sutcliffe JL.

Cancer Res. 2009 Jul 15;69(14):5843-50. doi: 10.1158/0008-5472.CAN-08-4410. Epub 2009 Jun 23.

PMID:
19549907
4.

Integrin αvβ₆-Targeted SPECT Imaging for Pancreatic Cancer Detection.

Liu Z, Liu H, Ma T, Sun X, Shi J, Jia B, Sun Y, Zhan J, Zhang H, Zhu Z, Wang F.

J Nucl Med. 2014 Jun;55(6):989-94. doi: 10.2967/jnumed.113.132969. Epub 2014 Apr 7.

PMID:
24711651
5.

99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.

Zhu X, Li J, Hong Y, Kimura RH, Ma X, Liu H, Qin C, Hu X, Hayes TR, Benny P, Gambhir SS, Cheng Z.

Mol Pharm. 2014 Apr 7;11(4):1208-17. doi: 10.1021/mp400683q. Epub 2014 Feb 24.

PMID:
24524409
6.

Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis.

John AE, Luckett JC, Tatler AL, Awais RO, Desai A, Habgood A, Ludbrook S, Blanchard AD, Perkins AC, Jenkins RG, Marshall JF.

J Nucl Med. 2013 Dec;54(12):2146-52. doi: 10.2967/jnumed.113.120592. Epub 2013 Oct 28.

PMID:
24167080
7.

Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.

Ueda M, Fukushima T, Ogawa K, Kimura H, Ono M, Yamaguchi T, Ikehara Y, Saji H.

Biochem Biophys Res Commun. 2014 Mar 14;445(3):661-6. doi: 10.1016/j.bbrc.2014.02.086. Epub 2014 Feb 26.

PMID:
24583127
8.

The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.

Hausner SH, Bauer N, Hu LY, Knight LM, Sutcliffe JL.

J Nucl Med. 2015 May;56(5):784-90. doi: 10.2967/jnumed.114.150680. Epub 2015 Mar 26.

PMID:
25814519
9.

18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.

Hackel BJ, Kimura RH, Miao Z, Liu H, Sathirachinda A, Cheng Z, Chin FT, Gambhir SS.

J Nucl Med. 2013 Jul;54(7):1101-5. doi: 10.2967/jnumed.112.110759. Epub 2013 May 13.

PMID:
23670900
10.

Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect.

Singh AN, McGuire MJ, Li S, Hao G, Kumar A, Sun X, Brown KC.

Theranostics. 2014 May 15;4(7):745-60. doi: 10.7150/thno.7811. eCollection 2014.

PMID:
24883124
11.

111In-Diethylenetriamine pentaacetic acid-NAVPNLRGDLQVLAQKVART.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Sep 6 [updated 2012 Nov 29].

PMID:
23193616
Free Books & Documents
12.

Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.

Hausner SH, Kukis DL, Gagnon MK, Stanecki CE, Ferdani R, Marshall JF, Anderson CJ, Sutcliffe JL.

Mol Imaging. 2009 Mar-Apr;8(2):111-21.

PMID:
19397856
13.

In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.

Coughlan L, Vallath S, Saha A, Flak M, McNeish IA, Vassaux G, Marshall JF, Hart IR, Thomas GJ.

J Virol. 2009 Jul;83(13):6416-28. doi: 10.1128/JVI.00445-09. Epub 2009 Apr 15.

PMID:
19369326
14.

Pharmacological Characterization of the αvβ6 Integrin Binding and Internalization Kinetics of the Foot-and-Mouth Disease Virus Derived Peptide A20FMDV2.

Slack RJ, Hafeji M, Rogers R, Ludbrook SB, Marshall JF, Flint DJ, Pyne S, Denyer JC.

Pharmacology. 2016;97(3-4):114-25. doi: 10.1159/000443180. Epub 2016 Jan 7.

PMID:
26734728
15.

In Vivo PET Imaging of the Cancer Integrin αvβ6 Using 68Ga-Labeled Cyclic RGD Nonapeptides.

Notni J, Reich D, Maltsev OV, Kapp TG, Steiger K, Hoffmann F, Esposito I, Weichert W, Kessler H, Wester HJ.

J Nucl Med. 2017 Apr;58(4):671-677. doi: 10.2967/jnumed.116.182824. Epub 2016 Dec 15.

PMID:
27980050
16.

Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6.

Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti PS, Sutcliffe JL.

Mol Imaging Biol. 2014 Aug;16(4):567-77. doi: 10.1007/s11307-013-0717-9.

PMID:
24448825
17.

A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects.

Zhang C, Kimura R, Abou-Elkacem L, Levi J, Xu L, Gambhir SS.

J Nucl Med. 2016 Oct;57(10):1629-1634. Epub 2016 May 26.

PMID:
27230926
18.

Cerenkov luminescence imaging of αv β6 integrin expressing tumors using (90) Y-labeled peptides.

Satpati D, Hausner SH, Bauer N, Sutcliffe JL.

J Labelled Comp Radiopharm. 2014 Jul;57(9):558-65. doi: 10.1002/jlcr.3215. Epub 2014 Jul 8.

PMID:
25042833
19.

PEGylated 4-[18F]fluorobenzoyl-NAVPNLRGDLQVLAQKVART.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Jul 17 [updated 2009 Oct 1].

PMID:
20641219
Free Books & Documents
20.

Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.

Allen MD, Thomas GJ, Clark S, Dawoud MM, Vallath S, Payne SJ, Gomm JJ, Dreger SA, Dickinson S, Edwards DR, Pennington CJ, Sestak I, Cuzick J, Marshall JF, Hart IR, Jones JL.

Clin Cancer Res. 2014 Jan 15;20(2):344-57. doi: 10.1158/1078-0432.CCR-13-1504. Epub 2013 Oct 22.

PMID:
24150233

Supplemental Content

Support Center